The Activity of Human NK Cells Towards 3D Heterotypic Cellular Tumor Model of Breast Cancer. / Leonteva, Anastasia; Abdurakhmanova, Maria; Bogachek, Maria et al.
In: Cells, Vol. 14, No. 14, 1039, 08.07.2025.Research output: Contribution to journal › Article › peer-review
}
TY - JOUR
T1 - The Activity of Human NK Cells Towards 3D Heterotypic Cellular Tumor Model of Breast Cancer
AU - Leonteva, Anastasia
AU - Abdurakhmanova, Maria
AU - Bogachek, Maria
AU - Belovezhets, Tatyana
AU - Yurina, Anna
AU - Troitskaya, Olga
AU - Kulemzin, Sergey
AU - Richter, Vladimir
AU - Kuligina, Elena
AU - Nushtaeva, Anna
N1 - This research was funded by the grant of the STATE PROGRAM OF THE «SIRIUS» FEDERAL TERRITORY, «Scientific and technological development of the «Sirius» Federal Territory» (AGREEMENT NO. 27-03 DATED 27 SEPTEMBER 2024).
PY - 2025/7/8
Y1 - 2025/7/8
N2 - Due to the complexity of modeling tumor-host interactions within the tumor microenvironment in vitro, we developed a 3D heterotypic cellular breast cancer (BC) model. We generated spheroid models using MCF7, MDA-MB-231, and SK-BR-3 cell lines alongside cancer-associated (BrC4f) and normal (BN120f) fibroblasts in ultra-low attachment plates. Stromal spheroids (3Df) were formed using a liquid overlay technique (graphical abstract). The YT cell line and peripheral blood NK (PB-NK) cells were used as immune components in our 3D model. In this study, we showed that stromal cells promoted tumor cell aggregation into spheroids, regardless of the initial proliferation rates, with NK cells accumulating in fibroblast-rich regions. The presence of CAFs within the model induced alterations in the expression levels of MICA/B and PD-L1 by tumor cells within the 3D-2 model. The feasibility of utilizing a 3D cell BC model in combination with cytokines and PB-NKs was evaluated. We observed that IL-15 and IL-2 enhanced NK cell activity within spheroids, whereas TGFβ had varying effects on proliferation depending on the cell type. Stimulation with IL-2 and IL-15 or TGFβ1 altered PB-NK markers and stimulated their differentiation into ILC1-like cells in 3D models. These findings underscore the regulatory function of CAFs in shaping the response of the tumor microenvironment to immunotherapeutic interventions.
AB - Due to the complexity of modeling tumor-host interactions within the tumor microenvironment in vitro, we developed a 3D heterotypic cellular breast cancer (BC) model. We generated spheroid models using MCF7, MDA-MB-231, and SK-BR-3 cell lines alongside cancer-associated (BrC4f) and normal (BN120f) fibroblasts in ultra-low attachment plates. Stromal spheroids (3Df) were formed using a liquid overlay technique (graphical abstract). The YT cell line and peripheral blood NK (PB-NK) cells were used as immune components in our 3D model. In this study, we showed that stromal cells promoted tumor cell aggregation into spheroids, regardless of the initial proliferation rates, with NK cells accumulating in fibroblast-rich regions. The presence of CAFs within the model induced alterations in the expression levels of MICA/B and PD-L1 by tumor cells within the 3D-2 model. The feasibility of utilizing a 3D cell BC model in combination with cytokines and PB-NKs was evaluated. We observed that IL-15 and IL-2 enhanced NK cell activity within spheroids, whereas TGFβ had varying effects on proliferation depending on the cell type. Stimulation with IL-2 and IL-15 or TGFβ1 altered PB-NK markers and stimulated their differentiation into ILC1-like cells in 3D models. These findings underscore the regulatory function of CAFs in shaping the response of the tumor microenvironment to immunotherapeutic interventions.
KW - 3D cancer cell models
KW - breast cancer
KW - cancer-associated fibroblast
KW - co-culture
KW - immunotherapy
KW - natural killer cell
KW - patient-derived cell culture
KW - spheroids
KW - stromal cell
KW - tumor microenvironment
UR - https://www.mendeley.com/catalogue/0a9a4005-9769-3eea-bd8f-cba4dc288a66/
UR - https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=105011651090&origin=inward
U2 - 10.3390/cells14141039
DO - 10.3390/cells14141039
M3 - Article
C2 - 40710292
VL - 14
JO - Cells
JF - Cells
SN - 2073-4409
IS - 14
M1 - 1039
ER -
ID: 68633623